On the CUSP: March 2024

Publications

• Dr. Ren Ostrom, Dr. Isabella Cattani-Cavalieri, Dr. Francisco Nuñez, Jordyn Margolis,  and PhD candidate Camelia Anicolaesei published Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ in JoVE Journal
• Dr. Rachita Sumbria, Dr. Nataraj Jagadeesan, Dr. Devaraj Chandrashekar, and Chuli Roules worked with others on “Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer’s disease mice” for the Journal of Translational Medicine.
• Dr. Jennifer Ko published “Exploring LGBTQ+ cultural competency and DEI in continuing education: A cross-sectional review of U.S. pharmacy legislation” alongside others for the Journal of American Pharmacists Association.
• Dr. Jelena Lewis and PharmD candidate Rosa Le published “Sotagliflozin for broad heart failure treatment” in Topics in Evidence-Based Pharmacy Practice for McGraw Hill
• Dr. Sherif Elshahawi, Dr. Nagaraju Mupparapu, Basir Syed, Diem Nguyen, Thao Vo, and Angelica Trujillo published “Selective late-stage functionalization of tryptophan-containing peptides to facilitate bioorthogonal tetrazine ligation” in Organic Letters
• Dr. Jason Yamaki, Dr. Richard Beuttler, and PharmD candidate Mirna Mikhail worked with others to publish “Characterizing Antibiotic Regimen Modification Behavior, Patient Characteristics, and Outcomes for Patients with Gram-Negative Bacterial Infections, A Retrospective Single-Center Study” in Antibiotics

Grants

• Dr. Miao Zhang was awarded a R15 from National Institute of Neurological Disorders and Stroke for over $434,000 for his study titled “Channelopathy of KCa2.3 and Zimmermann-Laband syndrome”.
• Dr. Young Woo Nam received a Career Development Award from the American Heart Association for his study titled “Structure-Function Studies of Cardiac KCa2.2 and KCa2.3 channels”. Dr. Surya Nauli, Dr. Miao Zhang, Dr. Keykavous Parang, and Dr. Nipavan Chiamvimonvat will serve as his mentors.

Presentations

Oral (e.g., Platform Presentations, Symposiums, Plenaries, Keynotes)

• Dr. Jeff Goad collaborated on “Addressing Gaps in Vaccine Access and Coverage. National Foundation for Infectious Diseases”
• Dr. Kamaljit Kaur presented “A novel peptide-drug conjugate targeting EGFR, DAVA THINK TANK on Antibody Drug Conjugates & Bispecifics” and “Keratin 1 – a phage display-identified target for peptide-drug conjugate” in Victoria, British Columbia, Canada
• Dr. Kamaljit Kaur presented “Peptide-drug conjugates targeting cell-surface keratin 1 for treatment of triple-negative breast cancer” at ACS Spring 2024
• Dr. Neeloufar Fakourfar and E. Nguyen presnted “Management of Chronic Kidney Disease Provider Inservice” at Providence St Joseph Heritage Medical Group in Garden Grove, CA
• Dr. Neeloufar Fakourfar and PharmD candidate Tiffany Thomas presented “Muscle Mass Loss & GLP-1 Receptor Agonists” at the California Educator Lunch and Learn at Providence Medical Foundation

Awards and Recognitions

• Dr. Jeff Goad was awarded the Fellow of the American Society of Health-System Pharmacists (FASHP).
• Dr. Kamaljit Kaur was invited to be part of “THINK TANK on Antibody Drug Conjugates & Bispecifics” by DAVA Oncology held in Victoria, Canada, which included ~ 60 oncologists, translational researchers, and biotech professionals.
• Dr. Keykavous Parang was promoted to Project Scientist Step III, Division of Nephrology and Hypertension in Department of Medicine at University of California, Irvine, School of Medicine.
• Dr. Rachita Sumbria has been invited by the National Institutes of Health and National Institute of Aging to present at a workshop on BBB transport in aging and Alzheimer’s disease in April: Blood-Brain Barrier Transport in Aging and Alzheimer’s Disease | National Institute on Aging (nih.gov)
• Dr. Rachita Sumbria received the 2024 Chapman Woman of Distinction Award.

Quotables (Faculty in the News)

• Dr. Jeff Goad was quoted in a USA Today article; COVID-19 is waning but these viruses are still hanging around as we head into early spring stating that “But as with influenza B, the trend for rotavirus was altered during the past few years by the COVID-19 pandemic. … It used to be more predictable … Eventually, we’ll get into a stable pattern and we’re already starting to see that.”